NIH Director Page NIH Health Information Page NIH Impact NIH Fact Sheets NIH Social Media and Outreach
EurekAlert! - National Institutes of Health  
LINKS

Resources

 

NIH Main

 

NIH Research News

 

Funded News

 
  For News & Research
  NIH Videos
  eColumn: NIH Research Matters
  NIH News in Health
  NIH Fact Sheets
 
  Additional Resources
  NIH Home Page
 

About NIH

  NIH Health Information
  Pub Med
  MedlinePlus
  Clinical trials.gov
  More News and Events Sources
  NIH News and Events, Special Interest
 
  RSS Feed RSS Feed
  Back to EurekAlert!
 

 


Department of Health and Human Services

News from the National Institutes of Health

Funded News


Key: Meeting M      Journal J      Funder F

Showing releases 2876-2900 out of 3575.

<< < 111 | 112 | 113 | 114 | 115 | 116 | 117 | 118 | 119 | 120 > >>

Public Release: 11-Mar-2014
Proceedings of the National Academy of Sciences
Cancer cells don't take 'drunken' walks through the body
Biologists have believed that cancers cells spread through the body in a slow, aimless fashion, resembling a drunk who can't walk straight. They now know that's true in a flat petri dish, but not in the three-dimensional space of an actual body.
National Institutes of Health

Contact: Phil Sneiderman
prs@jhu.edu
443-997-9907
Johns Hopkins University

Public Release: 11-Mar-2014
Cerebral Cortex
A new cell type is implicated in epilepsy caused by traumatic brain injury
Traumatic brain injury is a risk factor for epilepsy, though the relationship is not understood. A new study published in Oxford Journals' Cerebral Cortex identifies increased levels of a specific neurotransmitter as a contributing factor. The findings suggest that damage to a specific type of brain cell plays a role in the development of epilepsy after a traumatic brain injury.
The Epilepsy Foundation, NIH/National Institute of Neurological Disorders and Stroke, NIH/National Institute of General Medical Sciences, NIH/National Institute on Aging, Cure Alzheimer's Fund

Contact: Siobhan Gallagher
Siobhan.gallagher@tufts.edu
617-636-6586
Tufts University, Health Sciences Campus

Public Release: 11-Mar-2014
Public Health Reports
Prescriptions for opioids stabilizing after fivefold increase in 10-year span
To support the appropriate use of opioids and inform public health interventions to prevent drug abuse, most states have implemented a prescription drug monitoring program (PDMP). Researchers at Columbia University's Mailman School of Public Health evaluated the impact of these state-wide programs and found that after tripling until 2007, annual rates of prescriptions for opioid analgesics have stabilized although the effects of PDMPs on opioid dispensing vary markedly by state.
NIH/National Institute on Drug Abuse

Contact: Stephanie Berger
sb2247@columbia.edu
212-305-4372
Columbia University's Mailman School of Public Health

Public Release: 11-Mar-2014
AAOS 2014 Annual Meeting
Research consortium identifies predictors of successful ACL reconstruction
Researchers have found that a patient's age and the type of tissue graft have a direct impact on ACL reconstructive surgery outcomes, according to an exhibit presented March 11 at the 2014 American Academy of Orthopaedic Surgeons annual meeting in New Orleans.
National Institutes of Health, Center for Education and Research on Therapeutics -- Agency of Health

Contact: Laura Ambro
ambrol@ccf.org
216-636-5876
Cleveland Clinic

Public Release: 11-Mar-2014
Proceedings of the Royal Society B
Empathy chimpanzees offer is key to understanding human engagement
New findings show that chimpanzees exhibit flexibility in their empathy, just as humans do. This may help explain the evolution of how and when humans engage with others and choose to offer flexibility, and how we can do so more.
National Institutes of Health

Contact: Lisa Newbern
lisa.newbern@emory.edu
404-727-7709
Emory Health Sciences

Public Release: 11-Mar-2014
Nature Communications
New technique uses ATP as trigger for targeted anti-cancer drug delivery
Biomedical engineering researchers have developed a new technique that uses adenosine-5'-triphosphate, the so-called 'energy molecule,' to trigger the release of anti-cancer drugs directly into cancer cells. Early laboratory tests show it increases the effectiveness of drugs targeting breast cancer.
National Institutes of Health

Contact: Matt Shipman
matt_shipman@ncsu.edu
919-515-6386
North Carolina State University

Public Release: 11-Mar-2014
Arthritis & Rheumatology
Glucosamine fails to prevent deterioration of knee cartilage, decrease pain
A short-term study found that oral glucosamine supplementation is not associated with a lessening of knee cartilage deterioration among individuals with chronic knee pain. Findings published in Arthritis & Rheumatology, a journal of the American College of Rheumatology journal, indicate that glucosamine does not decrease pain or improve knee bone marrow lesions -- more commonly known as bone bruises and thought to be a source of pain in those with osteoarthritis.
Beverage Institute for Health & Wellness, The Coca-Cola Company, NIH/National Institute of Arthritis, Musculoskeletal and Skin Diseases

Contact: Dawn Peters
sciencenewsroom@wiley.com
781-388-8408
Wiley

Public Release: 10-Mar-2014
Annals of Clinical and Translational Neurology
Detecting, testing, treating rare diseases: Technology delivers new era of personalization
A team of researchers from the National Institutes of Health, Emory University and Cedars-Sinai -- specialists in identifying and treating very rare diseases -- used three innovative tools to detect a previously unknown gene mutation, test potential therapies in the lab, and initiate personalized drug treatment for a boy with a lifelong history of uncontrollable seizures that caused significant impact on his cognitive and social development.
NIH/Undiagnosed Diseases Program, NIH/National Institute of Neurological Disorders and Stroke, Cedars-Sinai Diana and Steve Marienhoff Fashion Industries Guild Endowed Fellowship in Pediatric Neuromuscular Disorders

Contact: Sandy Van
sandy@prpacific.com
808-526-1708
Cedars-Sinai Medical Center

Public Release: 10-Mar-2014
American Journal of Transplantation
New organ transplant strategy aims to better prevent rejection
Organ-transplant recipients often reject donated organs, but a new, two-pronged strategy developed by UC San Francisco researchers to specifically weaken immune responses that target transplanted tissue has shown promise in controlled experiments on mice.
Joyce and Fred Nichols Family, Korea Foundation for International Cooperation of Science and Technology, National Institutes of Health

Contact: Jeffrey Norris
jeffrey.norris@ucsf.edu
415-502-6397
University of California - San Francisco

Public Release: 10-Mar-2014
Biophysical Journal
Penn researchers model a key breaking point involved in traumatic brain injury
Even the mildest form of a traumatic brain injury, better known as a concussion, can deal permanent, irreparable damage. Now, an interdisciplinary team of researchers at the University of Pennsylvania is using mathematical modeling to better understand the mechanisms at play in this kind of injury, with an eye toward protecting the brain from its long-term consequences.
National Science Foundation, National Institutes of Health, US Department of Defense

Contact: Evan Lerner
elerner@upenn.edu
215-573-6604
University of Pennsylvania

Public Release: 10-Mar-2014
Therapy for your marriage -- without the therapy
'Reconcilable Differences' was first published to wide acclaim in 2000. The new second edition is substantially enhanced with insights gleaned from an ongoing 5-year grant from the National Institutes of Health, awarded to University of Miami researcher Dr. Brian Doss. The new edition takes couples through a three-step process and can be an effective, convenient, inexpensive alternative to face-to-face therapy, said Doss.
National Institutes of Health

Contact: Annette Gallagher
a.gallagher1@umiami.edu
305-284-1121
University of Miami

Public Release: 10-Mar-2014
Cancer Research
A signal to spread: Wistar scientists identify potent driver of metastasis
An international team of researchers led by scientists at The Wistar Institute have discovered and defined LIMD2, a protein that can drive metastasis, the process where tumors spread throughout the body. Wistar scientists have also developed and patented a monoclonal antibody that may one day be used as a prognostic test to see if tumors have LIMD2, and plans are underway to create inhibitors -- potential drugs that may target cells that produce LIMD2.
National Institutes of Health, Samuel Waxman Cancer Research Foundation, Susan G. Komen, O'Neill Foundation for Melanoma

Contact: Greg Lester
glester@wistar.org
215-898-3943
The Wistar Institute

Public Release: 10-Mar-2014
NIH grant to create Center for Excellence for Translational Research at Columbia's CII
W. Ian Lipkin, director of the Center for Infection and Immunity and John Snow Professor of Epidemiology at Columbia University's Mailman School of Public Health, has received an award of up to $31 million over a five-year period by NIH to establish the Center for Research in Diagnostics and Discovery under the auspices of a new National Institute of Allergy and Infectious Diseases program entitled Centers of Excellence for Translational Research.
National Institutes of Health

Contact: Stephanie Berger
sb2247@columbia.edu
212-305-4372
Columbia University's Mailman School of Public Health

Public Release: 10-Mar-2014
ACS Photonics
Diagnosing diseases with smartphones
University of Houston researchers are developing a disease diagnostic system that offers results that could be read using only a smart phone and a $20 lens attachment. This new device relies on specific chemical interactions that form between something that causes a disease -- a virus or bacteria, for example -- and a molecule that bonds with that one thing only, like a disease-fighting antibody.
National Institutes of Health, Welch Foundation

Contact: Jeannie Kever
jekever@uh.edu
713-743-0778
University of Houston

Public Release: 10-Mar-2014
New England Journal of Medicine
Moffitt Cancer Center pioneers worldwide standard in diagnosing melanoma
Moffitt Cancer Center researchers have been instrumental in making significant improvements to the diagnostic procedure called sentinel node biopsy for melanoma patients and teaching this procedure to physicians from around the world.
NIH/National Cancer Institute, National Institutes of Health, Australia and New Zealand Melanoma Trials Group

Contact: Kimberly Polacek
kim.polacek@moffitt.org
813-745-7408
H. Lee Moffitt Cancer Center & Research Institute

Public Release: 10-Mar-2014
Journal of Clinical Oncology
New prostate cancer treatment convenient, less expensive, but may be riskier
A faster and less expensive form of radiotherapy for treating prostate cancer may come at a price, according to a new study by Yale School of Medicine researchers -- a higher rate of urinary complications.
NIH/National Cancer Institute

Contact: Karen N. Peart
karen.peart@yale.edu
203-432-1326
Yale University

Public Release: 10-Mar-2014
Journal of Clinical Investigation
Unique individual demonstrates desired immune response to HIV virus
One person's unique ability to fight HIV has provided key insights into an immune response that researchers now hope to trigger with a vaccine, according to findings reported by a team that includes Duke Medicine scientists.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Sarah Avery
sarah.avery@duke.edu
919-660-1306
Duke University Medical Center

Public Release: 10-Mar-2014
Proceedings of the National Academy of Sciences
Several FDA-approved anti-cancer drugs induce stem cell tumors, perhaps thwarting therapy
In a surprise finding, University of Massachusetts Amherst and Harvard researchers discovered that several chemotherapeutics that do stop fast growing tumors have the opposite effect on stem cells in the same animal, causing them to divide too rapidly. Not only is the finding of clinical interest, but with this study they successfully used a new non-traditional tool for assessing drugs using stem cells in the fruit fly gut, the first author says.
National Institutes of Health Challenge Grant

Contact: Janet Lathrop
jlathrop@admin.umass.edu
413-545-0444
University of Massachusetts at Amherst

Public Release: 9-Mar-2014
Nature
Stem cell study opens door to undiscovered world of biology
For the first time, researchers have shown that an essential biological process known as protein synthesis can be studied in adult stem cells -- something scientists have long struggled to accomplish.
Cancer Prevention and Research Institute of Texas, NIH/National Institute on Aging

Contact: Lisa Warshaw
lisa.warshaw@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center

Public Release: 9-Mar-2014
Nature Chemical Biology
UNC researchers create new tool to unravel the mysteries of metastasis
Researchers at the UNC School of Medicine have devised a new biochemical technique that will allow them and other scientists to delve much deeper than ever before into the specific cellular circuitry that keeps us healthy or causes disease.
National Institutes of Health

Contact: Mark Derewicz
mark.derewicz@unch.unc.edu
919-923-0959
University of North Carolina Health Care

Public Release: 9-Mar-2014
Nature Medicine
Blood test identifies those at-risk for cognitive decline, Alzheimer's within 3 years
Researchers have discovered and validated a blood test that can predict with greater than 90 percent accuracy if a healthy person will develop mild cognitive impairment or Alzheimer's disease within three years.
National Institutes of Health, US Department of Defense

Contact: Karen Teber
km463@georgetown.edu
Georgetown University Medical Center

Public Release: 7-Mar-2014
SPIE DSS
Journal of Biomedical Optics
New high-tech glasses detect cancer cells during surgery
Scientists at Washington University School of Medicine in St. Louis and the University of Arizona in Tucson led by Samuel Achilefu have created a pair of high-tech glasses that help surgeons visualize cancer cells during surgeries. The technology, reported in the SPIE Journal of Biomedical Optics, incorporates custom video and a head-mounted display capable of capturing signal from any fluorescent molecular agent injected into a patient that attaches to cancer cells, making them glow.
NIH/National Cancer Institute, National Institutes of Health

Contact: Amy Nelson
amy@spie.org
360-685-5478
SPIE--International Society for Optics and Photonics

Public Release: 7-Mar-2014
Biomaterials
Research on 3-D scaffolds sets new bar in lung regeneration
Innovative research efforts in the field of tissue regeneration, including pioneering discoveries by the University of Vermont's Daniel Weiss, M.D., Ph.D., and colleagues, hold promise for the estimated 12.7 million people with chronic obstructive pulmonary disorder, the third leading cause of death in the US.
National Institutes of Health

Contact: Jennifer Nachbur
jennifer.nachbur@uvm.edu
802-656-7875
University of Vermont

Public Release: 7-Mar-2014
UT Arlington undergrad honored for research on antibiotic resistant infection
One of 60 students selected in the Council on Undergraduate Research's Posters on the Hill competition is looking for a way to stop a dangerous, hospital-acquired disease. Emmanuel Fordjour started working in the lab of a National Institutes of Health-funded researcher when he was just a sophomore.
National Institutes of Health

Contact: Traci Peterson
tpeterso@uta.edu
817-521-5494
University of Texas at Arlington

Public Release: 7-Mar-2014
PLOS ONE
Ever-so-slight delay improves decision-making accuracy
Researchers have found that decision-making accuracy can be improved by postponing the onset of a decision by a mere fraction of a second. The results could further our understanding of neuropsychiatric conditions characterized by abnormalities in cognitive function and lead to new training strategies to improve decision-making in high-stake environments. The study was published in the March 5 online issue of the journal PLOS ONE.
German Research Foundation, National Institutes of Health

Contact: Karin Eskenazi
ket2116@columbia.edu
212-342-0508
Columbia University Medical Center

Showing releases 2876-2900 out of 3575.

<< < 111 | 112 | 113 | 114 | 115 | 116 | 117 | 118 | 119 | 120 > >>

     
   

HOME    DISCLAIMER    PRIVACY POLICY    CONTACT US
Copyright ©2014 by AAAS, the science society.